Walkner Condon Financial Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Walkner Condon Financial Advisors's EXAS Position: Q1 2026 in Review
Walkner Condon Financial Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 11,217 shares — an estimated $1.03M sold.
Walkner Condon Financial Advisors first reported a position in EXAS in Q4 2020 and held it in 20 quarters. The position peaked at $1.16M in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Walkner Condon Financial Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Walkner Condon Financial Advisors sold 11,217 Exact Sciences shares in Q1 2026, an estimated $1.03M.
- Walkner Condon Financial Advisors first reported a position in Exact Sciences in Q4 2020 and held it in 20 quarters.
- Walkner Condon Financial Advisors's Exact Sciences position peaked at $1.16M in Q2 2023.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Walkner Condon Financial Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.